Heparin seems to reduce progression of COVID-19 in hospitalized people with moderate symptoms but not for the critically ill. Study author states that more research required to find the therapeutic “sweet spot”.

Dr. Barry Dworkin

Medical Mythbusting Commentary for August 5, 2021

Heparin seems to reduce progression of COVID-19 in hospitalized people with moderate symptoms but not for the critically ill. Study author states that more research required to find the therapeutic "sweet spot". Play Now | Play in Popup | Download

Source:
Canadian-led studies suggest blood thinner can help moderately sick COVID-19 patients

Reference:
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Related posts:

  1. PM Trudeau, your flouting of pandemic health policy rules demoralizes the country. Armchair “physicians”, stop flaunting cherry-picked preprint studies as “the” evidence HCQ works when there are just as many that refute it. That is why proper investigation and meta-analysis are required.
  2. Two positive steps forward for treatment and testing of coronavirus.
  3. Old antipsychotic medication helps kill Methicillin Resistant Staph Aureus (MRSA)
  4. High dose treatment of HIV in newborns seems to confer a functional cure in reported instances.
Bitnami